Multiple sclerosis: Hematopoietic stem cell transplantation: Hope and hype

Nature Reviews Neurology

Volumn 5, Issue 6, 2009, Pages 300-302

  Stangel, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BETA INTERFERON; CYCLOPHOSPHAMIDE; DACLIZUMAB; GLATIRAMER; IMMUNOGLOBULIN; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; MULTIPLE SCLEROSIS; NONMYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; STEM CELL MOBILIZATION; THROMBOCYTOPENIA; TREATMENT RESPONSE; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; NOTE; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTIPLE SCLEROSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 68849131511     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.63     Document Type: Article

References (10)

1. Burt, R. K. et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: A phase i/ii study. Lancet Neurol. 8, 244-253 (2009).
2. Mancardi, G. & Saccardi, R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol. 7, 626-636 (2008).
3. Van Wijmeersch, B., Sprangers, B., Dubois, B., Waer, M. & Billiau, A. D. Autologous and allogeneic hematopoietic stem cell transplantation for multiple sclerosis: Perspective on mechanisms of action. J. Neuroimmunol. 197, 89-98 (2008).
4. Muraro, P. A. et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J. Exp. Med. 201, 805-816 (2005).
5. Coles, A. J. et al. Alemtuzumab vs interferon β-1a in early multiple sclerosis. N. Engl. J. Med. 359, 1786-1801 (2008).
6. Coles, A. J. et al. The window of therapeutic opportunity in multiple sclerosis: Evidence from monoclonal antibody therapy. J. Neurol. 253, 98-108 (2006).
7. Hauser, s. L. et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358 676-688 (2008).
8. Chen, J. T. et al. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology 66, 1935-1937 (2006).
9. Roccatagliata, L. et al. The long-term effect of AHSCT on MRI measures of MS evolution: A five-year follow-up study. Mult. Scler. 13, 108-1070 (2007).
10. Metz, I. et al. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 130, 1254-1262 (2007).